Beacon v2 and Beacon networks: A "lingua franca" for federated data discovery in biomedical genomics, and beyond.

Beacon GA4GH REST API clinical genomics data discovery data sharing

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
06 2022
Historique:
revised: 07 03 2022
received: 29 09 2021
accepted: 12 03 2022
pubmed: 18 3 2022
medline: 25 5 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

Beacon is a basic data discovery protocol issued by the Global Alliance for Genomics and Health (GA4GH). The main goal addressed by version 1 of the Beacon protocol was to test the feasibility of broadly sharing human genomic data, through providing simple "yes" or "no" responses to queries about the presence of a given variant in datasets hosted by Beacon providers. The popularity of this concept has fostered the design of a version 2, that better serves real-world requirements and addresses the needs of clinical genomics research and healthcare, as assessed by several contributing projects and organizations. Particularly, rare disease genetics and cancer research will benefit from new case level and genomic variant level requests and the enabling of richer phenotype and clinical queries as well as support for fuzzy searches. Beacon is designed as a "lingua franca" to bridge data collections hosted in software solutions with different and rich interfaces. Beacon version 2 works alongside popular standards like Phenopackets, OMOP, or FHIR, allowing implementing consortia to return matches in beacon responses and provide a handover to their preferred data exchange format. The protocol is being explored by other research domains and is being tested in several international projects.

Identifiants

pubmed: 35297548
doi: 10.1002/humu.24369
pmc: PMC9322265
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-799

Subventions

Organisme : Medical Research Council
ID : MC_PC_18031
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19024
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S003703/1
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Human Mutation published by Wiley Periodicals LLC.

Références

Nat Biotechnol. 2022 Jun;40(6):817-820
pubmed: 35705716
Pharmgenomics Pers Med. 2018 Apr 10;11:59-66
pubmed: 29692621
Nucleic Acids Res. 2021 Jan 8;49(D1):D82-D85
pubmed: 33175160
Hum Mutat. 2015 Oct;36(10):957-64
pubmed: 26224250
Stud Health Technol Inform. 2015;216:574-8
pubmed: 26262116
Nat Commun. 2022 Jan 13;13(1):391
pubmed: 35027557
Eur J Hum Genet. 2021 Sep;29(9):1325-1331
pubmed: 34075208
Hum Mutat. 2022 Jun;43(6):791-799
pubmed: 35297548
PLoS Genet. 2018 Dec 26;14(12):e1007752
pubmed: 30586411
Cell Genom. 2021 Nov 10;1(2):
pubmed: 35072136
Eur J Hum Genet. 2021 Sep;29(9):1337-1347
pubmed: 34075210
Cell Genom. 2021 Nov 10;1(2):
pubmed: 35311178
JMIR Med Inform. 2021 Jul 30;9(7):e21929
pubmed: 34328424
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
Nucleic Acids Res. 2022 Jan 7;50(D1):D1216-D1220
pubmed: 34718739
Stud Health Technol Inform. 2015;210:180-4
pubmed: 25991126
Stud Health Technol Inform. 2021 May 27;281:138-142
pubmed: 34042721
Database (Oxford). 2021 Jul 17;2021:
pubmed: 34272855
Nucleic Acids Res. 2020 Jan 8;48(D1):D845-D855
pubmed: 31680165
Nat Biotechnol. 2019 Mar;37(3):220-224
pubmed: 30833764
JAMIA Open. 2020 Sep 11;3(3):472-486
pubmed: 33426479
J Gen Intern Med. 2014 Aug;29 Suppl 3:S780-7
pubmed: 25029978
Annu Rev Anim Biosci. 2015;3:57-111
pubmed: 25689317
Nucleic Acids Res. 2022 Jan 7;50(D1):D980-D987
pubmed: 34791407

Auteurs

Jordi Rambla (J)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), PRBB, Barcelona, Spain.

Michael Baudis (M)

Department of Molecular Life Sciences, University of Zurich and Swiss Institute of Bioinformatics, Zurich, Switzerland.

Roberto Ariosa (R)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Tim Beck (T)

Department of Genetics & Genome Biology, University of Leicester, Leicester, UK.

Lauren A Fromont (LA)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Arcadi Navarro (A)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Department of Experimental and Health Sciences, IBE, Institute of Evolutionary Biology (UPF-CSIC), Universitat Pompeu Fabra. PRBB, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Universitat Pompeu Fabra, Barcelona, Spain.
Barcelona Beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.

Rahel Paloots (R)

Department of Molecular Life Sciences, University of Zurich and Swiss Institute of Bioinformatics, Zurich, Switzerland.

Manuel Rueda (M)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Gary Saunders (G)

European Infrastructure for Translational Medicine, EATRIS, Amsterdam, The Netherlands.

Babita Singh (B)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

John D Spalding (JD)

ELIXIR Finland; CSC - IT Center for Science Ltd, Espoo, Finland.

Juha Törnroos (J)

ELIXIR Finland; CSC - IT Center for Science Ltd, Espoo, Finland.

Claudia Vasallo (C)

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Colin D Veal (CD)

Department of Genetics & Genome Biology, University of Leicester, Leicester, UK.

Anthony J Brookes (AJ)

Department of Genetics & Genome Biology, University of Leicester, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH